Tag: Impel NeuroPharma Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Impel NeuroPharma Inc.

Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering

Added to Collection on: 2021-04-22 22:41:15

Tags for this article:

Initial public offering
Financial markets
Financial economics
Finance
Stock market
Corporate finance
U.S. Securities and Exchange Commission
Public offering
Prospectus
Security
Registration statement
Impel NeuroPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Analysts Offer Insights on Healthcare Companies: Ikena Oncology (NASDAQ: IKNA), Impel ...

Added to Collection on: 2021-07-02 09:22:30

Tags for this article:

Impel NeuroPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Impel NeuroPharma Enters Into a $50 Million Debt Financing Agreement With Oxford Finance LLC ...

Added to Collection on: 2021-07-07 12:00:00

Tags for this article:

Health sciences
Health
Food and Drug Administration
Clinical research
Design of experiments
Drug discovery
Pharmaceutical industry
Clinical trial
Prescription Drug User Fee Act
Silicon Valley Bank
Oxford Finance LLC
Seattle
Impel NeuroPharma Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 ...

Added to Collection on: 2021-08-05 12:00:00

Tags for this article:

Finance
Pharmaceutical companies
Economy of New York City
NASDAQ
Financial markets
Alnylam Pharmaceuticals
Dow Jones Industrial Average
Arbutus Biopharma
NASDAQ-100
Nasdaq, Inc.
Maravai LifeSciences Holdings, Inc.
AbSci CORP
Novo Nordisk A/S
Alkermes Plc
Innoviva Inc
Sanofi
Cytek Biosciences Inc.
Horizon Therapeutics Public Limited Company
Eli Lilly and Company
DexCom Inc.
Bio-Rad Laboratories Inc.
Laboratory Corporation of America Holdings
Myriad Genetics Inc.
Translate Bio Inc
Protagonist Therapeutics Inc
ResMed Inc.
Edwards Lifesciences Corporation
BeyondSpring Inc.
Monte Rosa Therapeutics Inc.
Nuvalent Inc.
REPLIGEN CORPORATION
Alnylam Pharmaceuticals Inc.
BioNTech SE
Johnson & Johnson
Bristol-Myers Squibb Company
Zoetis Inc.
Genmab A/S
Moderna, Inc.
Impel NeuroPharma Inc.
Quest Diagnostics Incorporated
Immuneering Corporation
Intuitive Surgical Inc

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval ...

Added to Collection on: 2021-08-06 11:37:30

Tags for this article:

Life Sciences
Companies
Biotechnology
Economy of New York City
NASDAQ
Alnylam Pharmaceuticals
AstraZeneca
Maravai LifeSciences Holdings, Inc.
Orthopediatrics Corp
Novo Nordisk A/S
Alkermes Plc
Innoviva Inc
BioCryst Pharmaceuticals Inc.
Erasca Inc.
PAVMED INC.
Celldex Therapeutics Inc.
Caribou Biosciences Inc.
Bio-Rad Laboratories Inc.
Edwards Lifesciences Corporation
Oramed Pharmaceuticals Inc.
Monte Rosa Therapeutics Inc.
REPLIGEN CORPORATION
Alnylam Pharmaceuticals Inc.
Genmab A/S
Moderna, Inc.
Bio-Techne Corporation
Impel NeuroPharma Inc.
Immuneering Corporation
Cortexyme Inc.
Intuitive Surgical Inc
AtriCure Inc.

Click the tags to see associated articles and topics

View Article Details
Impel NeuroPharma Announces Second Quarter 2021 Financial Results and Provides Corporate ...

Added to Collection on: 2021-08-16 12:11:15

Tags for this article:

Financial markets
Finance
Corporate finance
Financial economics
Earnings per share
Income statement
Convertible bond
Balance sheet
Preferred stock
Convertible security
Financial statement
Generally Accepted Accounting Principles
Impel NeuroPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Investor Confidence Shakens After Impel NeuroPharma Inc. (NASDAQ: IMPL) Share Prices ...

Added to Collection on: 2021-09-07 15:56:15

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Share
Stock
NASDAQ
Dividend
Initial public offering
Kohlberg Kravis Roberts
Earnings per share
Impel NeuroPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Impel NeuroPharma Inc. (NASDAQ: IMPL) Stock: Performance And Outlook - Marketing Sentinel

Added to Collection on: 2021-09-15 10:52:30

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Equity securities
Corporate finance
Economy of New York City
NASDAQ
Share
Stock
Initial public offering
Impel NeuroPharma Inc.

Click the tags to see associated articles and topics

View Article Details